Alignment Healthcare News

UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating

MT NewswiresMay 3 23:30

Buy Rating Affirmed for Alignment Healthcare Amid Strong Q1 Performance and Positive 2024/2025 Outlook

TipRanksMay 3 09:06

Stifel: Maintains Alignment Healthcare (ALHC.US) rating, adjusted from buy to buy rating, and adjusted target price from $11.00 to $9.00.

Zhitong FinanceApr 24 01:01

Alignment Healthcare Analyst Ratings

BenzingaApr 24 00:58

Stifel Maintains Buy on Alignment Healthcare, Lowers Price Target to $9

BenzingaApr 24 00:58

Piper Sandler Downgrades Alignment Healthcare to Neutral, Lowers Price Target to $6

BenzingaMar 6 22:17

Alignment Healthcare Analyst Ratings

BenzingaMar 6 19:02

Buy Rating Affirmed for Alignment Healthcare Amidst Strong Q4 Performance and Positive 2024 Outlook

TipRanksMar 1 14:06

Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), TG Therapeutics (TGTX) and Amicus (FOLD)

TipRanksFeb 29 18:40

UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating

MT NewswiresFeb 29 01:59

Alignment Healthcare (ALHC) Receives a Buy From TD Cowen

TipRanksFeb 28 20:48

Alignment Healthcare Analyst Ratings

BenzingaJan 24 18:31

Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating

MT NewswiresJan 9 22:51

Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Alignment Healthcare (ALHC) and 10x Genomics (TXG)

TipRanksJan 9 18:11

Alignment Healthcare Analyst Ratings

BenzingaJan 9 18:05

Alignment Healthcare (ALHC) Gets a Buy From Goldman Sachs

TipRanksJan 9 00:45

Alignment Healthcare Analyst Ratings

BenzingaDec 21, 2023 23:14

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Adverum Biotechnologies (ADVM) and Alignment Healthcare (ALHC)

TipRanksNov 8, 2023 13:51

Analysts' Top Healthcare Picks: GlycoMimetics (GLYC), Alignment Healthcare (ALHC)

TipRanksNov 3, 2023 22:20

Alignment Healthcare Analyst Ratings

BenzingaNov 2, 2023 20:34